Ocugen, Inc. (OCGN)

1.96 +0.10 (+5.38%) USD  |  NASDAQ  |  Mar 04, 16:00
1.94 -0.02 (-1.02%) Pre-Market: 08:15
More

Ocugen Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for OCGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
MannKind Corp. Upgrade
CorMedix, Inc. Upgrade
Alector, Inc. Upgrade
Phathom Pharmaceuticals, Inc. Upgrade
Keros Therapeutics, Inc. Upgrade